Description

With ​the ​approval ​of ​T-Vec ​de-risking ​the ​oncolytic ​virus ​industry, ​investment ​and ​interest ​in ​this ​exciting ​space ​is ​growing. ​However, ​several ​hurdles ​remain. ​The ​Annual ​Oncolytic ​Virotherapy ​(OV) ​Summit ​is ​the ​industry ​focused ​summit ​dedicated ​to ​overcoming ​these ​difficulties ​to ​achieve ​translational ​success.

Start Your Registration